Alcon Cares Project 100 commits to reducing cataract blindness globally
Alcon, the global leader in eye care and a division of Novartis, has announced Alcon Cares Project 100, which aims to reduce... Read More
Licensing Deal: Hikma Pharma launches Basilea’s antibiotic Zevtera in Saudi Arabia
Basilea Pharmaceutica Ltd. announced that its partner Hikma Pharmaceuticals LLC has launched Basilea’s hospital antibiotic Zevtera (ceftobiprole) in Saudi Arabia in first... Read More
Medical Science Liaison (MSL) – A Career Option for Healthcare Professionals !
What is The Medical Science Liaison (MSL)? The Medical Science Liaison (MSL) is a specific job related role within the healthcare industries, e.g.... Read More
Big Pharma Acquisition: Takeda to acquire Shire for $62 billion
Takeda Pharmaceutical Co. of Japan has finalized an agreement to buy Shire PLC, the second-biggest biotech employer in Massachusetts, for $62 billion... Read More
Para IV notice: Endo International gets Paragraph IV notification on Vasostrict
Posted on19 Apr 2018
Comments0
Endo International plc announced that its subsidiaries, Par Pharmaceutical, Inc. and Par Sterile Products, LLC, have received a Notice Letter dated April... Read More
AstraZeneca, Daiichi Sankyo to introduce Nexium 10 & 20 mg granules for suspension, Sachet, in Japan
AstraZeneca K.K. and Daiichi Sankyo Company Limited announced the launch of proton pump inhibitor Nexium 10 mg and 20 mg granules for... Read More
Glenmark and Helsinn Group’s exclusive licensing deal for launch of Akynzeo in India and Nepal
Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, and Helsinn Group (“Helsinn”), a Swiss pharmaceutical group focused on building quality cancer... Read More
Natco launched a generic version of Teriflunomide tablets for the treatment of relapsing and remitting forms of multiple sclerosis in India
Natco Pharma launched a generic version of Teriflunomide for the treatment of relapsing and remitting forms of multiple sclerosis (RRMS), under its... Read More
Brand Positioning: GSK Consumer Healthcare Ltd launches Horlicks Protein+
Posted on19 Mar 2018
Comments0
GSK Consumer Healthcare Ltd, the maker of Horlicks, is making another attempt to diversify. The company is set to launch Horlicks Protein+,... Read More
New Launch: Hetero launches – Tafero-EM – FDC combo of ‘emtricitabine & tenofovir alafenamide’ in India
Hetero, one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs, announced the launch of the first generic... Read More